Clinical trial Recruiting at 4 sites Observational Ages 18 and up

Hyperacute Neurobiomarker Kinetics in Acute Brain Injury: What Happens in Minutes After Injury

Official title: Investigating the Significance of Protein Biomarkers During the Hyperacute Phase of Traumatic Brain Injury and Other CNS Conditions With Hypoxia/Hypoperfusion in Emergency and Prehospital Settings (CHARON)

Run by University of Pecs · NCT07782216 · Data updated 2026-11-12

This study tests how early brain injury biomarkers behave in the first minutes to hours after traumatic brain injury or cardiac arrest to see if they rise quickly enough to help with early care.

More Cardiac Arrest (CA) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment477 (estimated)
SponsorUniversity of Pecs
Academic / other
Locations4 sites (Pécs, Branya and 3 other locations)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedJune 30, 2028
Study endsDecember 31, 2028
Registry record updatedSeptember 29, 2026
Trial IDNCT07782216 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with polytrauma including TBI, or those treated for cardiac arrest in the prehospital setting, or severe TBI patients at hospital admission.

Probably not a fit

Patients under 18, those with pre-existing neurological or psychiatric conditions, or with extreme temperature disturbances at enrollment may not benefit from biomarker-based insights.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the time-dependent release of neurobiomarkers such as S100B, GFAP, NSE, UCH-L1, NFL, Tau, and related microRNAs and lipids during the hyperacute phase of brain injury. Participants include adults with polytrauma (including TBI), those treated for cardiac arrest in the prehospital setting, and severe TBI patients upon hospital admission, enrolled across multiple Hungarian sites. Blood samples are collected in the prehospital and ED windows to characterize biomarker kinetics and their potential for early prognostic use. The study aims to fill gaps about whether biomarker levels rise immediately or gradually and how quickly they become detectable. This knowledge could inform early decision-making in emergency care and triage.

Why it matters

Potential benefit: If successful, findings could enable earlier risk stratification and more timely interventions for brain injury patients.

How similar studies have gone: Prior work has established biomarker associations in brain injury, but precise hyperacute kinetics in prehospital/ED settings are less well characterized, making this approach novel yet grounded in established markers.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Age 18 years or older (all arms)
* Polytraumatized patients categorized as T1 triage by the first responder based on injury mechanism and/or sustained injuries, with intubation indicated by the first responder (Arm 1)
* Cardiac arrest treated in the prehospital setting (Arm 2)
* Severe traumatic brain injury enrolled at hospital admission (Arm 3)

Exclusion Criteria (all arms)

* Age under 18 years
* Pre-existing neurological or psychiatric conditions
* Hypothermia or hyperthermia at the time of enrollment
* Pregnancy

Where it's running

  • University of Pécs Clinical Center, Department of Emergency Medicine
    Pécs, Branya, Hungary
    Recruiting
  • Petz Aladár University Teaching Hospital, Emergency Department
    Győr, Győr-Moson-Sopron, Hungary
    Recruiting
  • Hungarian National Ambulance Service
    Budapest, Pest County, Hungary
    Recruiting
  • North Pest Central Hospital - Military Hospital, Emergency Centre
    Budapest, Pest County, Hungary
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.